APLS

Apellis Pharmaceuticals, Inc. - Common Stock (APLS)

About Apellis Pharmaceuticals, Inc. - Common Stock (APLS)

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Details

Daily high

$18.24

Daily low

$17.35

Price at open

$18.03

52 Week High

$42.47

52 Week Low

$16.10

Market cap

2.3B

Dividend yield

0.00%

Volume

1.7M

Avg. volume

1.9M

P/E ratio

-10.18

Apellis Pharmaceuticals, Inc. - Common Stock News